Drug Recalls

The U.S. Food and Drug Administration keeps track of drug recalls and safety alerts. Below is a list of product-wide, non-lot level, prescription drug recalls that could affect you.

To find out more, call Blue Cross Complete of Michigan’s Pharmacy Customer Service at 1-888-288-3231 or talk to your doctor or pharmacist. TTY users, call 1-888-988-0071.

2018

  • March 2, 2018 - FDA working with manufacturers to withdraw Zinbryta from the market in the United States. Biogen and Abbvie announced a voluntary withdrawal of Zinbryta (daclizumab), a multiple sclerosis (MS) drug, from the global market, noting concern about the drug’s evolving benefit/risk profile. No new patients will start taking Zinbryta or participate in clinical studies. The company has begun notifying health care professionals and patients, and the drug will be available for patients as needed until April 30, 2018.
    Patients using Zinbryta should not stop their medication without talking with their doctor and should contact their doctor immediately if they have any new and unexplained symptoms. Any questions or concerns about the withdrawal can be directed to the manufacturers’ service center at 1-800-456-2255 or the manufacturer’s website at www.zinbryta.com.

2017

2016

  • No product-wide recalls to report.

2015